PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportskidney transplantation
MeSH D016030 - kidney transplantation
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D017582:Renal replacement therapy
0 Companies
0 Drugs
Success rate
D016377:Organ transplantation
0 Companies
0 Drugs
Success rate
D013520:Urologic surgical procedures
0 Companies
0 Drugs
Success rate
D016030: 
Kidney transplantation
6 Companies
6 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Bristol Myers SquibbBelatacept Nulojix  2011-06-17 $26 M Y2013 
NovartisBasiliximab Simulect  1998-10-09   
PfizerSirolimus Rapamune  2001-03-13 $170 M Y2016 
RocheDaclizumab Zenapax  1999-02-26   
TevaTacrolimus Tacforius  2017-12-08   
Clinical Trials
Historical Success Rate
Phase 1
100%
42/42
Phase 2
45%
34/76
Phase 3
62%
29/47
Approved: 5Overall Success rate: 28%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Bristol Myers Squibb
Belatacept,
Mycophenolate sodium,
Benzocaine
Hansa Biopharma
Imlifidase
Novartis
Basiliximab,
Mycophenolate sodium,
Benzocaine,
Sodium chloride,
Sodium lactate,
ISCALIMAB,
SOTRASTAURIN,
TESIDOLUMAB,
Microcrystalline cellulose
Pfizer
Sirolimus,
Mycophenolate sodium
Roche
Daclizumab,
Mycophenolate sodium,
Benzocaine,
Pentamidine,
Chlormadinone acetate,
Sodium chloride,
Retinol
Teva
Tacrolimus
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use